Výsledky vyhledávání - "Pauline Dieringer"

Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancer

Autor: Curtis A. Pettaway, Patricia Troncoso, Pauline Dieringer, Lance C. Pagliaro, Louis L. Pisters, Xuemei Wang, Christopher J. Logothetis, Amado J. Zurita, John F. Ward, John W. Davis

Publikováno v: Prostate Cancer and Prostatic Diseases. 18:276-280

Prostate cancer persisting in the primary site after systemic therapy may contribute to emergence of resistance and progression. We previously demonstrated molecular characteristics of lethal cancer in the prostatectomy specimens of patients presenti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddf519934d029e89992d661bb5695e0a
https://doi.org/10.1038/pcan.2015.23

Zobrazit plný text záznamu

Thalidomide/Estramustine/Paclitaxel in Metastatic Androgen-Independent Prostate Cancer

Autor: Paul Mathew, Danai D. Daliani, Benjamin N. Bekele, Xian Zhou, Christopher J. Logothetis, I. Chen, Lance C. Pagliaro, Pauline Dieringer

Publikováno v: Clinical Genitourinary Cancer. 5:144-149

Background This is a phase I/II trial of thalidomide with estramustine and paclitaxel in men with androgen-independent prostate cancer (AIPC) who underwent previous chemotherapy. Patients and Methods Men with progressive AIPC were treated with oral t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bd934e4bff58c7e667ca88ae30b70c1
https://doi.org/10.3816/cgc.2006.n.031

Zobrazit plný text záznamu

Characterization of Patients with Androgen-Independent Prostatic Carcinoma Whose Serum Prostate Specific Antigen Decreased Following Flutamide Withdrawal

Autor: Juan Herrada, Pauline Dieringer, Christopher J. Logothetis

Publikováno v: Journal of Urology. 155:620-623

We confirmed the reported rate of prostate specific antigen (PSA) suppression after flutamide withdrawal in patients with metastatic prostatic carcinoma, increasing serum PSA and tumor progression following treatment with total androgen blockade (cas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39a34ea4ca047c4cf5da7683731572d5
https://doi.org/10.1016/s0022-5347(01)66468-1

Zobrazit plný text záznamu

Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanes

Autor: Alan J. Rodney, Eric Jonasch, Paul Mathew, Lance C. Pagliaro, Pauline Dieringer, Nizar M. Tannir

Publikováno v: Cancer. 106(10)

BACKGROUND The primary objective of the current study was to evaluate the effectiveness of capecitabine and gemcitabine in the treatment of patients with androgen-independent prostate cancer (AIPCa) who experienced disease progression after taxane th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88170b50f3c0ef84425d78347a11b945
https://pubmed.ncbi.nlm.nih.gov/16598751

Zobrazit plný text záznamu

Presurgical docetaxel (Doc) and androgen deprivation therapy (ADT) in lymph node-positive prostate cancer (PCa)

Autor: Louis L. Pisters, John W. Davis, Lance C. Pagliaro, Pauline Dieringer, Shi-Ming Tu, John C. Araujo, Jhingook Kim, Curtis A. Pettaway, Christopher J. Logothetis, Amado J. Zurita, John F. Ward

Publikováno v: Journal of Clinical Oncology. 29:4619-4619

4619 Background: For men newly diagnosed with PCa and lymph node (LN) metastasis, surgical control of the primary site is rarely considered. We conducted a phase II study of neoadjuvant Doc chemotherapy and 1 year of ADT followed by radical prostatec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d96826ea962cce0b8fc7ad44ca543d58
https://doi.org/10.1200/jco.2011.29.15_suppl.4619

Zobrazit plný text záznamu

Neoadjuvant trial of sunitinib malate and androgen ablation (ADT) in patients with localized prostate cancer (PCa) at high risk for recurrence

Autor: Curtis A. Pettaway, Pauline Dieringer, John C. Araujo, X. S. Wang, Christopher J. Logothetis, John F. Ward, Amado J. Zurita, Patricia Troncoso

Publikováno v: Journal of Clinical Oncology. 29:143-143

143 Background: Presurgical ADT does not improve long-term outcomes in patients (pts) with high-risk localized PCa. Since the VEGF and PDGF signaling pathways have been implicated in PCa progression, and ADT results in endothelial cell apoptosis in t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9af49da878ff5112fa0b92695c5faebc
https://doi.org/10.1200/jco.2011.29.7_suppl.143

Zobrazit plný text záznamu

Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer with prior taxane exposure

Autor: Lance C. Pagliaro, Pauline Dieringer, Nizar M. Tannir, Paul Mathew, Alan J. Rodney, E. Jonasch

Publikováno v: Journal of Clinical Oncology. 23:4750-4750

4750 Background: Single-agent response rates of 12% and 7% have been reported for capecitabine and gemcitabine, respectively, in androgen-independent prostate cancer (AIPCa). The primary objective ...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dc7a12a1c6cde08dd2a9f0e79e201b56
https://doi.org/10.1200/jco.2005.23.16_suppl.4750

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání